Angina refers to episodes of ischaemic chest pain or discomfort that lasts for 10 minutes or less and is alleviated with rest.1
After successful completion of this CPD activity, pharmacists should be able to:
Competency standards (2016) addressed: 1.1, 1.4, 1.5, 2.1, 2.3, 3.1, 3.5
Episodes of angina can be classified as an acute coronary syndrome; ST elevated and non-ST elevated myocardial infarctions (STEMI and NSTEMI), and high-risk unstable angina has been discussed in a previous article (Myocardial infarction, Australian Pharmacist, September 2020). Stable angina is a chronic ischaemic condition, with periodic episodes of consistent symptom severity, duration and predictable triggers (e.g. physical exertion).1 In unstable angina, there is an increase in the severity or duration of symptoms, or presentation of new symptoms.1
The management of angina involves treating and preventing episodes of angina as well as secondary prevention of cardiovascular events. This includes pharmacotherapy, lifestyle changes and sometimes revascu
THIS IS A CPD ARTICLE. YOU NEED TO BE A PSA MEMBER AND LOGGED IN TO READ MORE.